Wells Fargo analyst Mohit Bansal reiterated an Overweight rating and $1,280.00 price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

TD Cowen Reiterates Hold Rating on Hims and Hers (HIMS)February 6, 2026 6:04 AM Truist: 'Defending Lilly: LLY strong position helps guard their share in a crowded GLP-1 landscape'February 5, 2026 12:35 PM Leerink: 'there is no reason why HIMS shouldn't evaluate these launches for every subsequent weight loss product'February 5, 2026 10:25 AM Eli Lilly (LLY) PT Raised to $1,293 at BofA SecuritiesFebruary 5, 2026 10:02 AM Eli Lilly (LLY) PT Raised to $1,281 at Truist SecuritiesFebruary 5, 2026 9:38 AM Eli Lilly (LLY) PT Raised to $1,205 at Cantor FitzgeraldFebruary 5, 2026 9:27 AM TD Cowen: 'Eli Lilly (LLY) Confident Oral GLP-1s Will Expand Mkt'February 5, 2026 9:21 AM 'Eli Lilly (LLY) Extends Its Lead Into 2026'; PT Raised to $1,300 at BMO CapitalFebruary 5, 2026 9:12 AM Hims stock surges as Wegovy pill copy offered at $49, Novo shares fallFebruary 5, 2026 9:08 AM Eli Lilly (LLY) PT Raised to $1,300 at JPMorganFebruary 5, 2026 9:03 AM Eli Lilly (LLY) PT Raised to $1,313 at Morgan StanleyFebruary 5, 2026 8:08 AM Eli Lilly (LLY) PT Raised to $1,280 at Wells FargoFebruary 5, 2026 7:56 AM Eli Lilly (LLY) PT Raised to $1,300 at ScotiabankFebruary 5, 2026 7:20 AM Eli Lilly (LLY) PT Raised to $1,260 at Goldman SachsFebruary 5, 2026 6:52 AM Deutsche Bank: 'we think the combination of yesterday's day's fear / volatility and today's guide supports a +M/HSD% move for LLY'February 4, 2026 12:35 PM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)February 4, 2026 8:21 AM Bernstein Weighs In on Eli Lilly (LLY) Stock Following Novo Pre-ReleaseFebruary 4, 2026 7:56 AM